Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
about
Cyclin D as a therapeutic target in cancerCyclin D1 determines estrogen signaling in the mammary gland in vivoSubstitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature.Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function.Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers."DNA Binding Region" of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase CheckpointCyclin D2 is a GATA4 cofactor in cardiogenesis.Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors.Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.Proteomic identification of a direct role for cyclin d1 in DNA damage repair.Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma.An update on the implications of cyclin D1 in oral carcinogenesis.Overexpression of forkhead box J2 can decrease the migration of breast cancer cells.The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer.
P2860
Q28242623-03565CA3-A568-4540-9B82-D4BEB1D3CBD4Q28294725-1C2D819E-FA06-4D01-833C-46B50EABADA4Q30395158-C2538E14-FD0C-450D-A85E-353E9146EC00Q33627677-46197449-76D6-4FEE-AB67-84F867779330Q34737253-218046F2-47F8-480C-B747-B48D8A5659EAQ35685370-408B2535-8516-4CB1-96A7-FB7D7D453F71Q36534034-4E30E765-431F-4957-A0BB-21D769ECCBC8Q37544077-DF080D38-741E-4045-B278-5F9983661C7AQ37798827-E63F62E5-A945-4F2B-A40C-7E0F3137DFCEQ37825724-ED95EA35-5C55-44BE-84CE-0D48CAB36165Q38037046-A22075CB-C16E-427D-8633-045F4309385DQ38645797-2A79817E-8FC6-4E7C-A3C4-6A80C2D130ECQ38782834-149E589A-2C2E-4BB0-9F04-0424F7523442Q39375100-29D64AA7-D0EE-42D1-9E66-47CE9348442CQ40675603-C59809F4-9D44-4317-84DE-7F141D3FC47CQ51526098-6511AB91-40CE-4930-97BF-50CE8ACF3337
P2860
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@ast
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en-gb
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@nl
type
label
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@ast
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en-gb
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@nl
prefLabel
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@ast
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en-gb
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@nl
P2093
P3181
P356
P1433
P1476
Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells
@en
P2093
F Kashanchi
M E Bottazzi
R Van Duyne
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1210319
P407
P577
2007-08-02T00:00:00Z
P5875
P6179
1041736065